findmyKOL
Clinical trialNCT06027788RecruitingInterventional

CTSN Embolic Protection Trial

SponsorIcahn School of Medicine at Mount SinaiEnrollment842Acute Kidney InjuryCoronary Artery DiseaseDeliriumHeart Valve DiseaseIschemic Stroke
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • London Health Sciences Centre

    London, Ontario, Canada

    Michael Chu
    Recruiting
  • University of Ottawa Heart Institute

    Ottawa, Ontario, Canada

    Pierre Voisine
    Recruiting
  • Montreal Heart Institute

    Montreal, Quebec, Canada

    Denis Bouchard
    Not, yet, recruiting
  • Hôpital Laval

    Québec, Quebec, Canada

    Pierre Voisine
    Not, yet, recruiting
United States
  • Chi St. Vincent Heart Institute

    North Little Rock, Arkansas, United States

    Thurston Bauer
    Recruiting
  • Keck Hospital of the University of Southern California

    Los Angeles, California, United States

    Vaughn Starnes
    Recruiting
  • Emory University

    Atlanta, Georgia, United States

    Michael Halkos
    Recruiting
  • Indiana University

    Bloomington, Indiana, United States

    Withdrawn
  • Indiana Ohio Heart

    Fort Wayne, Indiana, United States

    Withdrawn
  • Ochsner Clinic

    New Orleans, Louisiana, United States

    Eugene Parrino
    Recruiting
  • Maine Medical Center

    Portland, Maine, United States

    Ansar Hassan
    Recruiting
  • Johns Hopkins Medicine

    Baltimore, Maryland, United States

    James S Gammie
    Recruiting
  • University of Maryland

    College Park, Maryland, United States

    Mehrdad Ghoreishi
    Recruiting
  • Massachusetts General Hospital

    Boston, Massachusetts, United States

    Nathaniel Langer
    Recruiting
  • University of Michigan

    Ann Arbor, Michigan, United States

    Recruiting
  • Mayo Clinic

    Rochester, Minnesota, United States

    Paul Tang
    Recruiting
  • Saint Luke'S Hospital of Kansas City

    Kansas City, Missouri, United States

    Keith Allen
    Recruiting
  • Columbia University Medical Center

    New York, New York, United States

    Isaac George
    Recruiting
  • Nyu Langone Hospital Brooklyn

    New York, New York, United States

    Withdrawn
  • New York Presbyterian-Cornell Medical Center

    New York, New York, United States

    Withdrawn
  • Northwell Health

    New York, New York, United States

    Pey-Jen Yu
    Recruiting
  • Montefiore Medical Center

    The Bronx, New York, United States

    Daniel Goldstein
    Recruiting
  • Duke University

    Durham, North Carolina, United States

    Jeffrey Gaca
    Recruiting
  • Cleveland Clinic

    Cleveland, Ohio, United States

    Marc Gillinov
    Recruiting
  • University Hospitals

    Cleveland, Ohio, United States

    Withdrawn
  • Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania, United States

    Michael Acker
    Recruiting
  • University of Virginia

    Charlottesville, Virginia, United States

    John Kern
    Not, yet, recruiting
  • West Virginia University

    Morgantown, West Virginia, United States

    James Mehaffey
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Sept 2023
Primary completion
1 Apr 2027
Completion
1 Apr 2027
Last update posted
29 May 2026
Registered enrollment
842
Registry id
NCT06027788

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.